GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (STU:27R) » Definitions » Cyclically Adjusted PS Ratio

RaySearch Laboratories AB (STU:27R) Cyclically Adjusted PS Ratio : 11.67 (As of Jun. 02, 2025)


View and export this data going back to 2020. Start your Free Trial

What is RaySearch Laboratories AB Cyclically Adjusted PS Ratio?

As of today (2025-06-02), RaySearch Laboratories AB's current share price is €27.55. RaySearch Laboratories AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €2.36. RaySearch Laboratories AB's Cyclically Adjusted PS Ratio for today is 11.67.

The historical rank and industry rank for RaySearch Laboratories AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:27R' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.64   Med: 6.69   Max: 30.47
Current: 12.1

During the past years, RaySearch Laboratories AB's highest Cyclically Adjusted PS Ratio was 30.47. The lowest was 2.64. And the median was 6.69.

STU:27R's Cyclically Adjusted PS Ratio is ranked worse than
96.45% of 338 companies
in the Healthcare Providers & Services industry
Industry Median: 1.195 vs STU:27R: 12.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted revenue per share data for the three months ended in Mar. 2025 was €0.883. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2.36 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


RaySearch Laboratories AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Cyclically Adjusted PS Ratio Chart

RaySearch Laboratories AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.26 3.71 3.58 4.09 8.76

RaySearch Laboratories AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.07 6.02 6.46 8.76 8.91

Competitive Comparison of RaySearch Laboratories AB's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted PS Ratio falls into.


;
;

RaySearch Laboratories AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

RaySearch Laboratories AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=27.55/2.36
=11.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, RaySearch Laboratories AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.883/132.8245*132.8245
=0.883

Current CPI (Mar. 2025) = 132.8245.

RaySearch Laboratories AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.256 99.995 0.340
201509 0.311 100.228 0.412
201512 0.412 100.276 0.546
201603 0.301 100.751 0.397
201606 0.371 101.019 0.488
201609 0.382 101.138 0.502
201612 0.576 102.022 0.750
201703 0.390 102.022 0.508
201706 0.427 102.752 0.552
201709 0.341 103.279 0.439
201712 0.602 103.793 0.770
201803 0.334 103.962 0.427
201806 0.400 104.875 0.507
201809 0.421 105.679 0.529
201812 0.623 105.912 0.781
201903 0.480 105.886 0.602
201906 0.520 106.742 0.647
201909 0.394 107.214 0.488
201912 0.653 107.766 0.805
202003 0.560 106.563 0.698
202006 0.456 107.498 0.563
202009 0.333 107.635 0.411
202012 0.458 108.296 0.562
202103 0.465 108.360 0.570
202106 0.446 108.928 0.544
202109 0.391 110.338 0.471
202112 0.536 112.486 0.633
202203 0.573 114.825 0.663
202206 0.441 118.384 0.495
202209 0.569 122.296 0.618
202212 0.701 126.365 0.737
202303 0.599 127.042 0.626
202306 0.602 129.407 0.618
202309 0.624 130.224 0.636
202312 0.781 131.912 0.786
202403 0.663 132.205 0.666
202406 0.823 132.716 0.824
202409 0.754 132.304 0.757
202412 0.818 132.987 0.817
202503 0.883 132.825 0.883

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RaySearch Laboratories AB  (STU:27R) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


RaySearch Laboratories AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB Business Description

Traded in Other Exchanges
Address
Eugeniavagen 18C, P.O. Box 3297, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.

RaySearch Laboratories AB Headlines

No Headlines